SIGN UP
LOG IN
A
ADMA
Adma Biologics
19.33
0.63+3.37%After Hours: 19.50 +0.17 +0.88%19:51 08/01 EDT
OPEN/PREV CLOSE18.37/18.70
TODAY RANGE18.22-19.44
VOL2.47M
MARKET CAP4.61B
52 WEEK RANGE10.21-25.67
AVG VOL (3M)3.08M
% TURNOVER1.04%
TURNOVER--
P/E (TTM)23.01
% RANGE6.52%
EPS(TTM)0.8402
P/E(FORWARD)31.69
P/B12.35
BVPS1.566
DIVIDEND--
P/S10.73
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP4.43B
SHARES OUTSTANDING238.73M
NEXT EARNINGS08/06-08/11
FREE FLOAT229.12M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Benzinga·1d ago
Is ADMA Biologics Gaining or Losing Market Support?
NASDAQ·3d ago
ADMA Biologics Shares Cross Above 200 DMA
Reuters·07/17 01:01
ADMA Biologics Inc. CEO Adam S. Grossman Reports Disposal of Common Shares
Benzinga·07/02 18:00
Is ADMA Biologics Gaining or Losing Market Support?
NASDAQ·06/27 12:11
Will Strong Asceniv Sales Drive ADMA Biologics Further?
Barchart·06/27 09:06
Implied Volatility Surging for ADMA Biologics Stock Options
NASDAQ·06/25 16:09
ADMA Biologics Becomes Oversold
Seeking Alpha·06/24 19:09
Calamos Timpani Small Cap Growth Fund Q1 2025 Commentary
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.